These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 22840842)

  • 61. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.
    Wang S; Goguen JD; Li F; Lu S
    Vaccine; 2011 Sep; 29(39):6802-9. PubMed ID: 21199697
    [TBL] [Abstract][Full Text] [Related]  

  • 62. YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense.
    Zheng Y; Lilo S; Mena P; Bliska JB
    PLoS One; 2012; 7(4):e36019. PubMed ID: 22563435
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-18 in human keratinocytes.
    Papale A; Kummer E; Galbiati V; Marinovich M; Galli CL; Corsini E
    Arch Toxicol; 2017 Apr; 91(4):1783-1794. PubMed ID: 27585668
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.
    Miller NC; Quenee LE; Elli D; Ciletti NA; Schneewind O
    Infect Immun; 2012 Apr; 80(4):1572-82. PubMed ID: 22252870
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis.
    Philipovskiy AV; Cowan C; Wulff-Strobel CR; Burnett SH; Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
    Infect Immun; 2005 Mar; 73(3):1532-42. PubMed ID: 15731051
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague.
    Comer JE; Sturdevant DE; Carmody AB; Virtaneva K; Gardner D; Long D; Rosenke R; Porcella SF; Hinnebusch BJ
    Infect Immun; 2010 Dec; 78(12):5086-98. PubMed ID: 20876291
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell-mediated protection against pulmonary Yersinia pestis infection.
    Parent MA; Berggren KN; Kummer LW; Wilhelm LB; Szaba FM; Mullarky IK; Smiley ST
    Infect Immun; 2005 Nov; 73(11):7304-10. PubMed ID: 16239527
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge.
    Sofer-Podesta C; Ang J; Hackett NR; Senina S; Perlin D; Crystal RG; Boyer JL
    Infect Immun; 2009 Apr; 77(4):1561-8. PubMed ID: 19124600
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague.
    Eisele NA; Lee-Lewis H; Besch-Williford C; Brown CR; Anderson DM
    Am J Pathol; 2011 Mar; 178(3):1190-200. PubMed ID: 21356370
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Study on the inflammasome nlrp3 and blimp-1/nlrp12 after keratinocyte exposure to contact allergens.
    Galbiati V; Cornaghi L; Papale A; Donetti E; Marinovich M; Corsini E
    Toxicol Lett; 2019 Oct; 313():130-136. PubMed ID: 31276767
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.
    Noel BL; Lilo S; Capurso D; Hill J; Bliska JB
    Clin Vaccine Immunol; 2009 Oct; 16(10):1457-66. PubMed ID: 19710295
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague.
    Olson RM; Dhariwala MO; Mitchell WJ; Skyberg JA; Anderson DM
    Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33257532
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response.
    Derbise A; Pierre F; Merchez M; Pradel E; Laouami S; Ricard I; Sirard JC; Fritz J; Lemaître N; Akinbi H; Boneca IG; Sebbane F
    J Infect Dis; 2013 May; 207(10):1535-43. PubMed ID: 23402825
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Roles of chaperone/usher pathways of Yersinia pestis in a murine model of plague and adhesion to host cells.
    Hatkoff M; Runco LM; Pujol C; Jayatilaka I; Furie MB; Bliska JB; Thanassi DG
    Infect Immun; 2012 Oct; 80(10):3490-500. PubMed ID: 22851745
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dynamics of Yersinia pestis and its antibody response in great gerbils (Rhombomys opimus) by subcutaneous infection.
    Zhang Y; Dai X; Wang X; Maituohuti A; Cui Y; Rehemu A; Wang Q; Meng W; Luo T; Guo R; Li B; Abudurexiti A; Song Y; Yang R; Cao H
    PLoS One; 2012; 7(10):e46820. PubMed ID: 23071647
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay.
    Li B; Zhou L; Guo J; Wang X; Ni B; Ke Y; Zhu Z; Guo Z; Yang R
    Infect Immun; 2009 Oct; 77(10):4356-61. PubMed ID: 19651863
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS; Wulff CR; Garvy BA; Straley SC
    Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The antibody spectrum after the inoculation of sensitive animals with Yersinia pestis and Yersinia pseudotuberculosis bacteria].
    Drobkov VI; Marakulin IV; Pogorel'skiĭ IP; Darmov IV; Smirnov EV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):81-5. PubMed ID: 8701667
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.
    Bowen W; Batra L; Pulsifer AR; Yolcu ES; Lawrenz MB; Shirwan H
    Vaccine; 2019 Sep; 37(38):5708-5716. PubMed ID: 31416643
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
    Lin JS; Park S; Adamovicz JJ; Hill J; Bliska JB; Cote CK; Perlin DS; Amemiya K; Smiley ST
    Vaccine; 2010 Dec; 29(2):357-62. PubMed ID: 20840834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.